Clinical Trial Search

Primary: Number of Early Postoperative Complications (Wound Infections, Seroma, Hematoma) — 9; 21; 2; 92 participants

Primary: Recurrence Rate — 6; 3 Participants

Primary: Postoperative Pain Scores — 5; 5; 4; 3 score on a scale

Primary: Time Taken to Complete Closure — 36.8; 48.9 seconds

Primary: Incisional Hernia — 32; 38 participants — p=0.60

Primary: Surgical Site Occurrence Rate — 1 subjects

Primary: The Frequency of Hernia Recurrence Diagnosed by Physical Exam or CT Scan (if Clinically Indicated) — 1 Participants

Primary: Number of Participants With Wound Occurrences — 0 Participants

Primary: Long-term Sequelae — 10; 13 percentage of participants

Primary: Composite Outcome of Diagnosis of Surgical Site Occurrence or Infection, Hospital Readmission, or Hernia Recurrence — 9; 9 Participants

Primary: Incidence of Wound Events — 53 participants

Primary: Hernia Recurrence Rate — 20 Participants

Primary: Primary Hernia Recurrence Rate at 24 Month Follow-up. — 3 Participants

Primary: Surgical Site Occurrences or Wound-related Events — 0; 10; 3; 4 Participants

Primary: Recurrence Rate of Hiatal Hernia Rate Based on Upper Gastrointestinal (UGI) Series — 6; 2; 8 Participants

Primary: Number of Patients With Inguinal Hernia Recurrence — 3; 0 participants — p=0.11

Primary: The Primary Endpoint is the Rate of Hernia Recurrence in Study Patients. — 0 participants

Primary: Number of Participants With Safe Fixation of Mesh and Closure of Peritoneum by Clinical Investigation During Hospital Stay and Telephone Interview at Six Weeks…

Primary: Number of Participants Who Develop Contact Dermatitis — 21; 18 Participants

Primary: Hernia Recurrence Rate — 17.3 % of subjects with recurrent hernia

Primary: Number of Participants With Early Postoperative Safety Events (Surgical Site Infection, Mesh-Related Adverse Events, or Reoperation) — 4; 0; 0; 0 Participants

Primary: Number of Subjects With a Hernia Recurrence Requiring Reoperation — 0 Participants

Primary: Operating Time From Skin Incision to Wound Closure — 39.2; 47.7 minutes

Primary: Number of Subjects Who Had an Additional Hernia Occur Following Surgery With Condensed Polytetrafluoroethylene (cPTFE, MotifMESH) Mesh — 0 participants

Primary: Number of Participants With Recurrent Ventral and Incision Hernias Post Repair With Phasix™ Mesh — 0 Participants

Primary: Hernia Recurrence Rate of Hernias Post Repair With Sepramesh. — 1 participants

Primary: Visual Analog Scale of Pain Activity — 50; 70 units on a scale

Primary: Number of Participants With Wound Complications — 16; 17 participants

Primary: Change From Baseline in Activities Assessment Scale at 3 Months — -7.49; -6.12 units on a scale

Primary: Number of Participants With Wound Occurrences Up to 45 Days Post Implantation — 11 Participants